Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
基本信息
- 批准号:7496763
- 负责人:
- 金额:$ 20.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-15 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAgeAge-YearsAged, 80 and overAgingAllelesAlzheimer&aposs DiseaseAmericanAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApolipoprotein EAscorbic AcidBrainCerebrumCessation of lifeCharacteristicsCholesterolClinicalCognitionCognitiveCohort StudiesCommitConditionDataDementiaDietDiseaseDropsDrug usageEnvironmental Risk FactorEpidemiologyExerciseFamily history ofFolateFrequenciesGeneticGenotypeGoalsHabitsHealthHomocysteineHomocystineIbuprofenImpaired cognitionIncidenceIndividualInjuryIntakeInvestigationLifeLife StyleLipidsLongevityLower ExtremityMeasuresMedical HistoryNeurofibrillary TanglesNumbersNutrientOxidative StressPathologyPerformancePharmaceutical PreparationsPopulationPrevalenceProteinsRangeRateReportingRiskRisk FactorsSampling StudiesSerum Folate LevelSocietiesVitaminsagedaging braincognitive functioncohortexperiencefallsfollow-upfunctional declinemembermortalityneuroinflammationnormal agingprospectivesocial
项目摘要
CLINICAL ANDPATHOLOGICAL STUDIES IN THE OLDEST OLD
In the next two decades, the numberof Americans aged 90 years and older will nearly double to over 3 million people.
Because previous studies have few, if any, subjects over 90 years of age, little is known about these pioneers or about
factors associated with successful aging and health in this group.
The goals of this proposal are to investigate clinical,genetic, and pathological factors associated with extreme old age.
We superimpose our investigations on the Leisure World Cohort Study, initiated in 1981. For over 20 years, cohort
members (N=13,979) have provided medical history and lifestyle information including morbid conditions, family
history, exercise, social activities, and medication use such as antioxidants and non-steroidal anti-inflammatorydrugs
(NSAIDS).
Our central hypothesis is that oxidative damage and inflammationin the brain results in aging, disease and death and
that intake of antioxidants and NSAIDS will slow cognitive decline and improvethe health of the oldest old.
Our Specific Aims are: (1) to examine factors associated with longevity in the 4,682 cohort members who reached age
90 compared to the 6734 who did not, (2) to determine the prevalence, incidence, and risk factors for dementia in 1,644
living cohort members in their tenth and eleventh decades, (3) to conduct longitudinal follow-up to measure rates of
cognitive and functional decline in these oldest old subjects, and (4) to complete our investigations with clinical
pathological correlates of brain aging in health and disease, focusing on the association of cerebral measures of
oxidative injury, inflammatorymarkers, and plaqueand tangle pathology as it relates to clinical status and previous use
of antioxidant and anti-inflammatorycompounds.
The Leisure World Cohort Study provides a unique population sample for the study of genetic and environmental
factors associated with longevity and successful aging in the oldest old. With a substantial cohort of committed
subjects and 20 years of prospective data, our proposed investigations can contribute much to the understanding of
cognition, functional abilities, and cerebral pathology in the oldest members of our society.
老年人的临床和病理学研究
未来20年,90岁及以上的美国人数量将几乎翻倍,达到300万以上。
由于之前的研究很少(如果有的话)年龄超过 90 岁的受试者,因此人们对这些先驱者或有关
与该群体成功老龄化和健康相关的因素。
该提案的目标是调查与高龄相关的临床、遗传和病理因素。
我们将我们的调查与 1981 年启动的休闲世界队列研究相结合。20 多年来,队列研究
会员 (N=13,979) 提供了病史和生活方式信息,包括疾病状况、家庭情况
病史、锻炼、社交活动和药物使用,例如抗氧化剂和非甾体抗炎药
(非甾体抗炎药)。
我们的中心假设是,大脑中的氧化损伤和炎症会导致衰老、疾病和死亡,
摄入抗氧化剂和非甾体抗炎药将减缓认知能力下降并改善老年人的健康。
我们的具体目标是:(1) 检查 4,682 名达到该年龄的队列成员中与长寿相关的因素
90 人与未这样做的 6734 人进行比较,(2) 确定 1,644 人中痴呆症的患病率、发病率和危险因素
10 岁和 11 岁的在世队列成员,(3) 进行纵向随访以衡量
这些年龄最大的老年受试者的认知和功能下降,以及(4)完成我们的临床研究
健康和疾病中大脑衰老的病理相关性,重点关注大脑测量的关联
氧化损伤、炎症标志物以及斑块和缠结病理学,因为它与临床状态和既往使用情况有关
抗氧化剂和抗炎化合物。
休闲世界队列研究为遗传和环境研究提供了独特的人群样本
与老年人的长寿和成功老龄化相关的因素。拥有大量致力于
主题和 20 年的前瞻性数据,我们提出的调查可以为理解做出很大贡献
我们社会最年长成员的认知、功能能力和脑病理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAUDIA H. KAWAS其他文献
CLAUDIA H. KAWAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAUDIA H. KAWAS', 18)}}的其他基金
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
- 批准号:
8166929 - 财政年份:2009
- 资助金额:
$ 20.39万 - 项目类别:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
- 批准号:
7951079 - 财政年份:2008
- 资助金额:
$ 20.39万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
7575781 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
6934497 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
8039091 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
7463369 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
6659008 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's disease
识别和理解重复 RNA 和 RAN 蛋白在阿尔茨海默病中的作用
- 批准号:
10833734 - 财政年份:2023
- 资助金额:
$ 20.39万 - 项目类别:
High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans
高强度间歇训练(HIIT)可减少老年退伍军人的虚弱并增强其恢复能力
- 批准号:
10539160 - 财政年份:2023
- 资助金额:
$ 20.39万 - 项目类别:
Cognitive aging in long-term breast cancer survivors
长期乳腺癌幸存者的认知衰老
- 批准号:
10566264 - 财政年份:2023
- 资助金额:
$ 20.39万 - 项目类别:
APE1 and Somatic Expansion in Huntington's Disease
APE1 和亨廷顿病的体细胞扩张
- 批准号:
10332662 - 财政年份:2022
- 资助金额:
$ 20.39万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder
阿尔茨海默病和术后神经认知障碍的血液 DNA 甲基化生物标志物
- 批准号:
10667556 - 财政年份:2022
- 资助金额:
$ 20.39万 - 项目类别: